Juvena Therapeutics
Juvena Therapeutics develops tissue-restorative biologics to address chronic muscle and age-related conditions.
About Juvena Therapeutics
Juvena Therapeutics develops biologic drug candidates by identifying and engineering human stem cell-secreted proteins into therapies that aim to restore tissue homeostasis and improve muscle and metabolic function. It uses a proprietary, AI-enabled discovery platform that maps the therapeutic potential of the secretome to disease phenotypes and advances selected proteins into engineered biologic medicines. The company’s pipeline includes engineered proteins for muscle regeneration and metabolic indications, with its lead candidate being evaluated in clinical studies for muscle-related disease. Juvena collaborates with partners to expand discovery efforts and explore new therapeutic targets using its computational and biological capabilities.
Company Facts
- Headquarters
- Palo Alto
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00011_00050
- Funding Stage
- early_stage_venture
- Total Funding
- $113,215,249
- Last Funding Type
- series_b
- Last Funding Date
- 2026-01-12
- Website
- juvenatherapeutics.com
Industries & Categories
Biopharma, Biotechnology, Health Care, Life Science
Social Links
Canonical: https://fsome.com/organization/juvena-therapeutics-23299 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.